glp 1 agonist heart disease GLP-1 Agonists in Cardiovascular Diseases: Mechanisms, Clinical Evidence, and Emerging Therapies Heart transplantation in the GLP-1
Description
The enhanced feeling of satiety associated with GLP-1s can also improve binge eating behaviors
Endocrinol Metab (Seoul) 40: 112124, 2025
Pharmacokinetic study Plasma agonist concentration after a single IP injection (24 nmol kg 1 ) was measured with an exendin-4 C-terminus-specific ELISA (Phoenix Pharmaceuticals), a peptide region that does not differ between agonists, hence equally detecting exendin-4 and exendin-phe1 (confirmed by analysis of known concentrations of each agonist)
These interactions may be: Additive (combined effect equals the sum of individual effects)
Sica, G
2024;187(14):360218 e20
